Dan Carlson Revisits VIP Picks: ATOM, HJLI, INMB, and TFFP

Dan Carlson of TW Research gives an update on 4 of his VIP Picks. Watch now to learn what Dan thinks of recent developments in Atomera (ATOM), Hancock Jaffe Laboratories (HJLI), INmune Bio (INMB), and TFF Pharmaceuticals (TFFP).

TW Research's Disclaimers & Disclosures: TW Research owns stock in the above names and has been compensated by INMB and TFFP for research articles on them. TW Research has not been compensated for production of this video. For a full list of disclaimers and disclosures, please visit TW Research Group, LLC http://tailwindsresearch.com/disclaimer/.

----------------

Recorded June 20th, 2021. VIP members get exclusive early access to most events including access to the full recordings with the Q&A session. Become a VIP member and view Q&A sessions and exclusive content: https://storytrading.com/vip-upgrade/

Check out StoryTrading here: https://www.storytrading.com/​

You can learn more about TW Research here: https://twresearchgroup.com

Disclaimer:
StoryTrading is not a registered investment advisor. Anything said in the video is for informational, educational, and entertainment purposes only and should not be considered as investment advice or a recommendation to invest in any particular security, strategy, or investment product. Investing in securities involves significant risk of loss. Past performance is no indication or guarantee of future results and the value of any investment you make may go up or down.

Visit our website to view our full disclaimer. https://www.storytrading.com/disclaimer/